Rs.66.80for 1 strip(s) (15 tablets each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Ozovil 50mg Tablet

Vildagliptin(50mg)

food interaction for Ozovil Tablet

alcohol interaction for Ozovil Tablet

pregnancy interaction for Ozovil Tablet

lactation interaction for Ozovil Tablet

food
alcohol
pregnancy
lactation
Ozovil Tablet may be taken with or without food.
None
CAUTION
It is not known whether it is safe to consume alcohol with Ozovil Tablet. Please consult your doctor.
CONSULT YOUR DOCTOR
Ozovil Tablet is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.
CONSULT YOUR DOCTOR
Ozovil Tablet may be unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. It should be used only if the expected benefit outweighs the potential risk. Please consult your doctor.
CONSULT YOUR DOCTOR

SALT INFORMATION FOR Ozovil 50mg Tablet

Vildagliptin(50mg)

Ozovil tablet uses

{med_name} is used in the treatment of type 2 diabetes mellitus. It is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes.

How ozovil tablet works

Ozovil Tablet is an antidiabetic medication. It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and postmeal sugar levels.

Common side effects of ozovil tablet

Hypoglycemia (low blood glucose level), Dizziness, Headache, Tremors, Fatigue, Nausea

SUBSTITUTES FOR Ozovil Tablet

515 Substitutes
515 Substitutes
Sorted By
RelevancePrice

Expert advice FOR Ozovil Tablet

  • Vildagliptin should be taken at the same time every day since this helps you remember to take it.
  • It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
  • Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremor and anxiety.
  • Be careful while driving or operating machinery until you know how Vildagliptin affects you.
  • Your doctor may check your kidney and liver function before starting treatment and regularly thereafter. Inform your doctor if you develop symptoms such as abdominal pain, fatigue, loss of appetite, darkened urine or yellowing of the eyes or skin (jaundice).

Frequently asked questions FOR Ozovil 50mg Tablet

Vildagliptin

Q. When should I take Ozovil Tablet?
You can take Ozovil Tablet tablets before, with or after meals. If you have been prescribed to take this medicine once daily, then take it in the morning. In case you have to take it twice daily, then you should prefer taking the first dose in the morning and the second dose in the evening.
Q. Does Ozovil Tablet cause hypoglycemia?
Yes, Ozovil Tablet may cause hypoglycemia (low blood sugar), but the chances are lesser as compared to other antidiabetic drugs. Evidence suggests that treatment with Ozovil Tablet has been shown to cause hypoglycemia in very rare cases. The risk is low even in those who are prone to hypoglycemia like elderly people or people being treated with insulin. However, the chance of hypoglycemia increases if Ozovil Tablet is taken along with other antidiabetic drugs.
Q. Does Ozovil Tablet cause weight gain?
No, Ozovil Tablet does not cause weight gain. Moreover, medicines, such as Ozovil Tablet, are generally supposed to decrease weight since they act by increasing satiety (feeling of fullness) and delaying emptying of the stomach. This further decreases hunger, restricting the patient from eating more than required.
Show More
Q. Is Ozovil Tablet the same as sitagliptin?
No, Ozovil Tablet is not the same as Sitagliptin, but both drugs belong to the same class. Additionally, these two drugs have a similar mechanism of decreasing blood glucose levels.

Content on this page was last updated on 01 October, 2026, by Dr. Rajeev Sharma (MBA, MBBS)